FDA Opened 16 Health Care Fraud Investigations In FY 2011; DoJ Net Tops $4 Billion
This article was originally published in The Pink Sheet Daily
HHS and the Department of Justice note actions taken last year in their Health Care Fraud and Abuse Control Program Annual Report for fiscal year 2011; enforcement actions net a record sum.
You may also be interested in...
One sign that the government is zealously going after the pharmaceutical industry for health care fraud is the line up of criminal investigations FDA has initiated.
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
In the first False Claims Act case alleging cGMP violations the government cites microbial contamination, split tablets and product mix-ups.